Solution of Tumor Data Analysis

In-depth study of the pathogenesis of oncology, and further search for effective, low-toxic, new anti-tumor drugs has become a priority task of major scientific research institutions and drug research and development enterprises. In order to meet the rapid development of life sciences and drug research and development, high-content imaging analysis technology is a new technology platform.High-content imaging analysis technology provides a brand-new high-throughput screening and evaluation platform for oncology research and development of anti-tumor drugs. It integrates high-resolution, intelligent, automated, and massive data.Big data of oncology medicine has shown extremely broad application prospects in clinical research, new drug development, early detection and other fields, and has become one of the important engines driving the development of oncology precision medicine. We adhere to and implement a big data strategy, establish a tumor gene big data platform, and promote the storage, integration, analysis, and application of tumor medical data.

Creative Proteomics tumor gene big data is based on genetic, mutation, immune, infection and other multi-dimensional digital tumor information, integrates and cleans clinical diagnosis and treatment information and follow-up information, and provides real-world tumor data for later data mining.

Solution of Tumor Data Analysis

Our Advantage

Mature and reliable Search for Solution of Tumor Data Analysis platform: rich project experience, participate in major projects, and publish high-level cooperation results.

The analysis contents and methods based on high-quality data analysis, pre-research and verification are indeed mature and feasible.

Please contact us to find out how we can help you achieve the next research breakthrough.

Learn More

* For Research Use Only. Not for use in the treatment or diagnosis of disease.

Related Services:


  • USA
  • Tel:
  • Fax:
  • Email:
  • Germany


Copyright © 2024 Creative Proteomics. All rights reserved.